Partnering to make a difference

Photo: WHO

We have active collaborations with over 150 partners, including ministries of health, bilateral and multilateral organizations, research and academic institutes, commercial partners, private-public partnerships, NGOs and over 80 clinical trial sites.

From the beginning, we have relied on key partnerships to address the challenges of both research and development (R&D) for poverty-related diseases.

We act as a bridge between the public and private sectors and our unique position allows us to bring together a diverse set of partners, helping to resolve technical, financial and logistical barriers to innovation while keeping the focus on the development of safe and effective diagnostic tests for low-resource settings. At FIND, we combine specific skills and resources from our various partners to achieve the greatest impact as quickly as possible. Our partners include:

  • Commercial companies, which have the technological know-how, but may not have the financial incentives necessary to invest heavily in poverty-related diseases, nor a deep understanding of the disease-causing agents
  • Academic world, which is often focused on basic research and conceptual innovation, but is ill-equipped for product development
  • International public health organizations and various NGOs and foundations, which play a major role in access to diagnostic products in endemic country markets
  • Public donors or philanthropic organizations, which provide essential funding but are not implementers, and
  • Ministries of health and disease control programmes, which manage healthcare systems in endemic countries but do not develop the technologies.

However, we do not focus just on product development. To ensure that our co-developed products have the intended impact for national health programmes and people in village communities, we also support early implementation through laboratory strengthening and the roll out of new diagnostic tools in remote endemic areas.